Common name: European mistletoe
Botanical name: Viscum album
© Martin Wall
Parts used and where grown
Mistletoe grows as a partial parasite on a variety of trees—particularly pine, apple,
plum, poplar, and spruce—across northern Europe and Asia. The young leafy twigs with
flowers are used. Mistletoe’s white berries are potentially toxic and should be avoided.
American mistletoe, various species of Phoradendron, are similar but have not been
widely studied. They should not be substituted for European mistletoe until more information
is available.
Mistletoe has been used in
connection with the following conditions (refer to the individual
health concern for complete information):
Historical or traditional use (may
or may not be supported by scientific studies)
The ancient Druids of northern Europe and other pagan groups revered mistletoe,
particularly when it infected oak trees (a rare occurrence). Over time, this reverence of
mistletoe was translated into the Christian ritual of hanging mistletoe over doorways at
Christmas. The custom of kissing under the mistletoe may be a remnant of pagan orgies held
before mistletoe altars.1
The name mistletoe is said to derive from the Celtic word for “all-heal.” This
correlates with its historical use for everything from nervous complaints to bleeding to
tumours.2 It is difficult to categorize all of the uses of mistletoe, particularly
when one looks at the vast number of uses for this herb in traditional Chinese and Korean
medicine. In the early 20th century, Rudolf Steiner created what is known as anthroposophical
medicine. This mystical system used a variety of unusual remedies, including special extracts
of mistletoe for injection. Steiner helped bring mistletoe into the modern era of scientific
research, particularly as a potential treatment for cancer.3
Active constituents
Several constituents have been shown to contribute to the medicinal action of mistletoe.
Most notable are mistletoe lectins (also called viscotoxins), choline derivatives, alkaloids,
polypeptides, and polysaccharides. Human pharmacological studies have found that mistletoe
extract given by injection stimulates immune
system function.4 5 6 Some test tube and animal studies
suggest that certain mistletoe constituents, including the alkaloids, can also kill cancer
cells.7 8 Numerous clinical trials have found that subcutaneous
injections of mistletoe extracts can help people with cancer of various organs, though some
have also failed to show any benefit.9 10 There is no evidence that
people with cancer would benefit from receiving mistletoe orally.
Mistletoe’s other uses have been less rigorously studied. Preliminary trials carried
out using oral mistletoe have found it can reduce the symptoms of high blood pressure, particularly headaches and
dizziness.11 12 However, mistletoe has a small (if any) effect on
actually lowering blood pressure.13
Test tube and animal studies suggest that mistletoe extracts can stimulate insulin secretion from pancreas cells and may improve
blood sugar levels in people with
diabetes.14 15 Given both mistletoe’s tradition around the
world for helping people with diabetes and these promising preclinical results, human clinical
trials are needed to establish mistletoe’s potential for this condition.
How much is usually taken?
Traditionally a cold water extract (cold infusion) is made by soaking 2–4 teaspoons
(10–20 grams) of chopped mistletoe in two cups (500 ml) of water overnight.16
This is taken first thing in the morning and can be sweetened with honey. Another batch is
left to steep during the day and drunk at bedtime. Alternately a hot tea can be made by
infusing 1 teaspoon (5 grams) of leaves in a cup (250 ml) of just-boiled water for 5–10
minutes. Two cups (500 ml) are consumed per day.17 A tincture, approximately 1/8
teaspoon (1/2 ml) three times per day, can also be used.
At least three standardised, injectable extracts have been studied in Europe: Iscador,
Helixor, and Eurixor. These products are not designed for self-treatment and are not
commercially available in the United States. Iscador is the only fermented extract of the
three, and each is standardised in a different way, making comparisons between the extracts
difficult. In addition, there are different forms of each extract taken from mistletoe growing
on different host trees. Typically, one weekly injection providing 1 mg of mistletoe lectin I
per kilogram of body weight is given. People interested in subcutaneous or other injectable
forms of mistletoe should consult with a physician.
Are there any side effects or interactions?
In the oral amounts mentioned above, mistletoe is rarely associated with side
effects.18 Two reports, however, have confirmed the danger of ingesting mistletoe
leaves and berries in large quantities, particularly when children accidentally eat the
berries at Christmas.19 20 Many of these exposures involved American
mistletoe and not European mistletoe. European mistletoe is less toxic than the American
species. If six to twenty berries or four to five leaves are eaten, then activated charcoal or
ipecac can be used at home to induce vomiting. Emergency room care is only indicated if more
than 20 berries or five leaves are ingested or if symptoms develop at lower levels of
exposure. Possible symptoms of overdose are nausea, vomiting, low blood pressure, or
dizziness.
Injectable forms of mistletoe may cause local redness and pain but otherwise have rarely
been associated with serious side effects. There is one case report of a severe allergic
reaction to an injected mistletoe preparation.21 Mistletoe is not recommended for
use in children, or for women during pregnancy
or breast-feeding.
At the time of writing, there were no well-known drug interactions
with mistletoe.
References
(To view, roll mouse over heading; to hide, click on heading)
1. Walker BG. The Woman’s Encyclopedia of Myths and
Secrets. San Francisco: Harper & Row, 1983, 661–3.
2. Duke JA. CRC Handbook of Medicinal Herbs. Boca Raton, FL: CRC
Press, 1985, 512–3.
3. Urech K. Mistletoe constituents and cancer therapy. J
Anthroposophical Med 1993;10:54–63.
4. Hajto T. Immunomodulatory effects of Iscador: A Viscum album
preparation. Oncology 1986;43(suppl 1):51–65.
5. Bocci B. Mistletoe (Viscum album) lectins as cytokine
inducers and immunoadjuvant in tumor therapy. A review. J Biol Reg Homeostatic Agents
1993;7:1–6.
6. Bloksma N, Schmiermann P, de Reuver M, et al. Stimulation of humoral
and cellular immunity by Viscum preparations. Planta Med 1982;46:221–7.
7. Jurin M, Zarkovic’ N, Hrzenjak M, Ilic’ Z. Antitumorous
and immunomodulatory effects of the Viscum album L preparation Isorel.
Oncology 1993;50:393–8.
8. Khwaja TA, Dias CB, Pentecost S. Recent studies on the anticancer
activities of mistletoe (Viscum album) and its alkaloids. Oncology
1986;43(suppl 1):42–50.
9. Yarnell E. Is Viscum album a potential treatment for
pancreatic cancer? HealthNotes Review 1999;6:88–90 [review].
10. Kleijnen J, Knipschild P. Mistletoe treatment for cancer. Review of
controlled trials in humans. Phytomedicine 1994;1:255–60.
11. Bowman IA. The everlasting mistletoe and the cardiovascular system.
Texas Heart Inst J 1990;17:310–4 [review].
12. O’Hare JP, Hoyt LH. Mistletoe in the treatment of hypertension.
New Eng J Med 1928;199:1207–13.
13. Weiss RF. Herbal Medicine. Gothenburg, Sweden: Ab Arcanum
and Beaconsfield, UK: Beaconsfield Publishers Ltd, 1985, 158–60.
14. Gray AM, Flatt PR. Insulin-secreting activity of the traditional
antidiabetic plant Viscum album (mistletoe). J Endocrinol
1999;160:409–14.
15. Swanson-Flatt SK, Day C, Bailey CJ, Flatt PR. Evaluation of
traditional plant treatments for diabetes: Studies in streptozotocin-diabetic mice. Acta
Diabetologica Latina 1989;26:51–5.
16. Weiss RF. Herbal Medicine. Gothenburg, Sweden: Ab Arcanum
and Beaconsfield, UK: Beaconsfield Publishers Ltd, 1985, 158–60.
17. Weiss RF. Herbal Medicine. Gothenburg, Sweden: Ab Arcanum
and Beaconsfield, UK: Beaconsfield Publishers Ltd, 1985, 158–60.
18. Weiss RF. Herbal Medicine. Gothenburg, Sweden: Ab Arcanum
and Beaconsfield, UK: Beaconsfield Publishers Ltd, 1985, 158–60.
19. Krenzelok EP, Jacobsen TD, Aronis J. American mistletoe exposures.
Am J Emerg Med 1997;15:516–20.
20. Spiller HA, Willias DB, Gorman SE, Sanftleban J. Retrospective study
of mistletoe ingestion. Clin Toxicol 1996;34:405–8.
21. Bauer C, Oppel T, Rueff F, Przybilla B. Anaphylaxis to viscotoxins of
mistletoe (Viscum album) extracts. Ann Allergy Asthma Immunol 2005;94:86–9.
Copyright © 2006 Healthnotes, Inc. All rights reserved.
www.healthnotes.com
Learn more about Healthnotes, the
company.
Learn more about the authors of
Healthnotes.
The information presented in Healthnotes is for informational purposes
only. It is based on scientific studies (human, animal, or in vitro), clinical
experience, or traditional usage as cited in each article. The results reported may not
necessarily occur in all individuals. For many of the conditions discussed, treatment with
prescription or over the counter medication is also available. Consult your doctor,
practitioner, and/or chemist for any health problem and before using any supplements or before
making any changes in prescribed medications. Information expires March 2007.